Germana Tognon

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Placebo Controlled

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio Gonzáles Martin, María Jesús Rubio, Florian Heitz, René Depont Christensen, Nicoletta Colombo, Toon Van Gorp, Margarita Romeo Marin, Isabelle L Ray-Coquard, Lydia Gaba, Alexandra Leary, Luis Miguel De Sande, Coriolan Lebreton, Andrés Redondo, Michel Fabbro, Maria-Pilar Barretina Ginesta, Philippe Follana, José Alejandro Pérez-Fidalgo, Manuel J Rodrigues, Ana Santaballa, Renaud Sabatier, Maria José Bermejo-Pérez, Jean-Pierre Lotz, Beatriz Pardo, Gloria Marquina, Luisa Sanchez Lorenzo, María Quindós, Purificación Estévez-García, Eva Guerra Alía, Luis Manso Sanchez, Victoria Casado, Stefan Kommoss, Germana Tognon, Stéphanie Henry, Ilan Bruchim, Ana Oaknin, Frédéric Selle
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Domenica Lorusso, Francesco Raspagliesi, Dominique Ronzulli, Giorgio Valabrega, Nicoletta Colombo, Carmela Pisano, Chiara Cassani, Germana Tognon, Stefano Tamberi, Giorgia Mangili, Serafina Mammoliti, Ugo De Giorgi, Filippo Greco, Anna Maria Mosconi, Enrico Breda, Grazia Artioli, Claudia Andreetta, Claudia Casanova, Rita Ceccherini, Antonio Frassoldati, Vanda Salutari, Serena Giolitto, Giovanni Scambia
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Domenica Lorusso, Francesco Raspagliesi, Dominique Ronzulli, Giorgio Valabrega, Nicoletta Colombo, Carmela Pisano, Chiara Cassani, Germana Tognon, Stefano Tamberi, Giorgia Mangili, Serafina Mammoliti, Ugo De Giorgi, Filippo Greco, Anna Maria Mosconi, Enrico Breda, Grazia Artioli, Claudia Andreetta, Claudia Casanova, Rita Ceccherini, Antonio Frassoldati, Vanda Salutari, Serena Giolitto, Giovanni Scambia
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Domenica Lorusso, Francesco Raspagliesi, Dominique Ronzulli, Giorgio Valabrega, Nicoletta Colombo, Carmela Pisano, Chiara Cassani, Germana Tognon, Stefano Tamberi, Giorgia Mangili, Serafina Mammoliti, Ugo De Giorgi, Filippo Greco, Anna Maria Mosconi, Enrico Breda, Grazia Artioli, Claudia Andreetta, Claudia Casanova, Rita Ceccherini, Antonio Frassoldati, Vanda Salutari, Serena Giolitto, Giovanni Scambia
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)